Personalized Medicine Discovery May Improve Hospitals’ Sepsis Outcomes
German-based diagnostics company identifies biomarkers that could help reduce sepsis costs, suggests basing a precision medicine initiative in the hospital ICU.
Health Networks and Hospitals
Hospital Administrators Will Need to Understand How the Chronobiome Could Impact Precision Medicine
Recent research into the human chronobiome has shown that the “normal” circadian rhythm can vary significantly in healthy individuals. This means that chronotherapies which are based on an average individual’s circadian rhythm may not be as efficacious for everyone.
Public Health vs. Precision Medicine: Is It Really an Either/Or Proposition?
As more precision medicine approaches are coming into practice, in some cases kickstarted by the COVID-19 pandemic, hospital and health system leaders are best advised to not pick sides in the one-size-fits-all versus tailor-made debate.
How Precision Medicine Can Help Patients with Cancer During the Coronavirus Pandemic
Stratifying cancer patients switched from adjuvant chemotherapy to targeted treatments during the coronavirus pandemic
How to Make Oil (IT) and Water (Physicians) Mix in Precision Medicine Initiatives
“Don’t underestimate the importance of aligning the interests of different stakeholders,” says the CTO of the Danish National Genome Center. Here are his tips for getting alignment on shared goals.
New PNAS Analysis Explains Results of Common Health Condition Precision Medicine Track
Study shows that the traditional approach to annual health assessments needs to change…
Dilemma for Hospitals and Health Systems: Finding the Productive Middle Ground in the Precision Medicine vs Population Health Debate
While a recent report suggests expanding or initiating precision medicine efforts is imminent among health systems, some worry that precision medicine may take away from population health. The task for hospital and health system leaders is to determine a complementing balance of both efforts A report from the Center for Connected Medicine demonstrates just how …
UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer
Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes…
Bridging the Gap Between the Clinical Possibilities and Economics of Precision Medicine
From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes…
3 Steps to Make Precision Medicine Part of the Medical Culture
Walking the fine line between not being the biggest risk taker and not being the last adopter, hospitals that offer genetic testing can expect their market share to increase and their payer mix to improve, according to LSUHSC’s Miele…